Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVExtend: Abaloparatide followed by Alendronate in Osteoporosis
NCT01657162Phase 3Completed
- Sponsor
- Radius Health Inc
- Start
- Nov 2012
- Primary completion
- Oct 2016
- Modality
- Peptides
- Countries
- 10
01
Overview
A Phase 3 trial of abaloparatide in postmenopausal osteoporosis, sponsored by Radius Health Inc. Started Nov 2012; status: completed.
02
Drugs
abaloparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01657162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01657162.